|
1 Indications And Usage Dacogen Is Indicated For Treatment Of Adult Patients With Myelodysplastic Syndromes (mds) Including Previously Treated And Untreated, De Novo And Secondary Mds Of All French-American-British Subtypes (refractory Anemia, Refractory Anemia With Ringed Sideroblasts, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts In Transformation, And Chronic Myelomonocytic Leukemia) And Intermediate-1, Intermediate-2, And High-Risk International Prognostic Scoring System Groups. Dacogen Is A Nucleoside Metabolic Inhibitor Indicated For Treatment Of Adult Patients With Myelodysplastic Syndromes (mds) Including Previously Treated And Untreated, De Novo And Secondary Mds Of All French-American-British Subtypes (refractory Anemia, Refractory Anemia With Ringed Sideroblasts, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts In Transformation, And Chronic Myelomonocytic Leukemia) And Intermediate-1, Intermediate-2, And High-Risk International Prognostic Scoring System Groups. ( 1 )
|